Triple-negative breast cancer (TNBC), a heterogeneous breast cancer subgroup defined by the absence of estrogen receptor, progesterone receptor and HER2/neu expression, is associated with the worst prognosis. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.